|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 24 October 2007
doi: 10.1242/dev.008367
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9148, USA.
* Author for correspondence (e-mail: eric.olson{at}utsouthwestern.edu)
SUMMARY
The myocyte enhancer factor 2 (MEF2) transcription factor acts as a lynchpin in the transcriptional circuits that control cell differentiation and organogenesis. The spectrum of genes activated by MEF2 in different cell types depends on extracellular signaling and on co-factor interactions that modulate MEF2 activity. Recent studies have revealed MEF2 to form an intimate partnership with class IIa histone deacetylases, which together function as a point of convergence of multiple epigenetic regulatory mechanisms. We review the myriad roles of MEF2 in development and the mechanisms through which it couples developmental, physiological and pathological signals with programs of cell-specific transcription.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Schwieger, A. Schuler, M. Forster, A. Engelmann, M. A. Arnold, R. Delwel, P. J. Valk, J. Lohler, R. K. Slany, E. N. Olson, et al. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C Blood, September 17, 2009; 114(12): 2476 - 2488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Diao, X. Wang, and Z. Wu SOCS1, SOCS3, and PIAS1 Promote Myogenic Differentiation by Inhibiting the Leukemia Inhibitory Factor-Induced JAK1/STAT1/STAT3 Pathway Mol. Cell. Biol., September 15, 2009; 29(18): 5084 - 5093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Lovato, M. M. Adams, P. W. Baker, and R. M. Cripps A Molecular Mechanism of Temperature Sensitivity for Mutations Affecting the Drosophila Muscle Regulator Myocyte Enhancer Factor-2 Genetics, September 1, 2009; 183(1): 107 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kuratomi, Y. Ohmori, M. Ito, K. Shimazaki, S.-i. Muramatsu, H. Mizukami, H. Uosaki, J. K. Yamashita, Y. Arai, K. Kuwahara, et al. The cardiac pacemaker-specific channel Hcn4 is a direct transcriptional target of MEF2 Cardiovasc Res, September 1, 2009; 83(4): 682 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Gordon, C. Pagiatakis, J. Salma, M. Du, J. J. Andreucci, J. Zhao, G. Hou, R. L. Perry, Q. Dan, D. Courtman, et al. Protein Kinase A-regulated Assembly of a MEF2{middle dot}HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells J. Biol. Chem., July 10, 2009; 284(28): 19027 - 19042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Yokoyama, U. Ohler, and G. A. Wray Measuring spatial preferences at fine-scale resolution identifies known and novel cis-regulatory element candidates and functional motif-pair relationships Nucleic Acids Res., July 1, 2009; 37(13): e92 - e92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sako, S. Fukuhara, T. Minami, T. Hamakubo, H. Song, T. Kodama, A. Fukamizu, J. S. Gutkind, G. Y. Koh, and N. Mochizuki Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2 J. Biol. Chem., February 27, 2009; 284(9): 5592 - 5601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Chen, T. E. Callis, and D.-Z. Wang microRNAs and muscle disorders J. Cell Sci., January 1, 2009; 122(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Liu, S. Bezprozvannaya, A. H. Williams, X. Qi, J. A. Richardson, R. Bassel-Duby, and E. N. Olson microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes & Dev., December 1, 2008; 22(23): 3242 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Khiem, J. G. Cyster, J. J. Schwarz, and B. L. Black A p38 MAPK-MEF2C pathway regulates B-cell proliferation PNAS, November 4, 2008; 105(44): 17067 - 17072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fazi and C. Nervi MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination Cardiovasc Res, September 1, 2008; 79(4): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Barbosa, M.-S. Kim, M. Ertunc, M. Adachi, E. D. Nelson, J. McAnally, J. A. Richardson, E. T. Kavalali, L. M. Monteggia, R. Bassel-Duby, et al. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function PNAS, July 8, 2008; 105(27): 9391 - 9396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wang, X. Li, M. Parra, E. Verdin, R. Bassel-Duby, and E. N. Olson Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7 PNAS, June 3, 2008; 105(22): 7738 - 7743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Kim, J. Fielitz, J. McAnally, J. M. Shelton, D. D. Lemon, T. A. McKinsey, J. A. Richardson, R. Bassel-Duby, and E. N. Olson Protein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance Mol. Cell. Biol., June 1, 2008; 28(11): 3600 - 3609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Liu, A. H. Williams, Y. Kim, J. McAnally, S. Bezprozvannaya, L. B. Sutherland, J. A. Richardson, R. Bassel-Duby, and E. N. Olson An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 PNAS, December 26, 2007; 104(52): 20844 - 20849. [Abstract] [Full Text] [PDF]
|
|
